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PDZ domaina b s t r a c t
iNOS lacks any phosphorylatable residue at its C-terminus despite displaying a 25-residue extension
known to block electron transfer and activity. We report that C-terminal deletions of iNOS increased
the cytochrome c reduction rate. Moreover, the interaction of the iNOS C-terminus with the PDZ
domains of EBP50 or CAP70 resulted not only in augmented reductase activity and greater NO
synthesis but also anticipated the formation of the air-stable semiquinone generated after NADPH
addition. Hence, the C-terminus of iNOS regulates the activity of the enzyme, albeit, unlike nNOS
and eNOS, displacement of the autoinhibitory element occurs upon binding to proteins with PDZ
domains.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In the immune system, iNOS releases large amounts of NO that
serves not only as a cytotoxic agent but also modulate the differen-
tiation of T helper cell subsets and the communication between
mesenchymal cells and T cells [1,2]. Mechanistically, all three
mammalian NOSs function in a similar way [3], using the three
substrates O2, NADPH and L-Arg, in the presence of ﬁve cofactors
(FAD, FMN, heme, H4B and Zn), to release NO together with
L-citrulline and NADP+. Binding of calmodulin to the interdomain
hinge that connects both domains activates electron transfer
from the carboxy-terminal reductase domain towards the
amino-terminal oxygenase domain [3–6]. When Bredt, Snyder
and coworkers cloned the nNOS gene [7] sequence comparison
revealed that the carboxy-terminal domain was homologous to
diﬂavin cytochrome P450 reductase, both displaying binding sites
for NADPH, which acted as the electron donor, as well as binding
sites for the ﬂavins FAD and FMN. Sequence identity was reported
to be 58% between the C-terminal 641 amino acids of nNOS and the
entire sequence of CYPOR. Thus, NOSs where classiﬁed as reduc-
tases prior to the discovery that they also bound heme.Subsequent cloning of iNOS [8] and eNOS [9] revealed that all three
mammalian NOSs showed carboxy-terminal extensions beyond
the homologous regions with CYPOR [10]. This carboxy-terminal
‘‘tail’’ absent in CYPOR is formed by 42 amino acids in bovine
eNOS, 33 in rat nNOS and 21 in mouse macrophage iNOS [10,11]
with the rate of NO synthesis in these isoforms inversely related
to the length of this carboxy-terminus extension [12,13].
Still, the reason for which NOSs have evolved introducing these
autoregulatory ‘‘lids’’ at their carboxy-terminus is not fully under-
stood. In both eNOS and nNOS, this C-terminal extension displays a
phosphorylation site (RXRXX(S/T)) for various protein kinases, such
as Akt/PKB and PKD [14–18]. Importantly, the puriﬁed eNOS
Ser1177Asp recombinant protein demonstrated a 2-fold increase
in NO production and a 2–4-fold increase in cytochrome c reduc-
tion when compared to its wild-type counterpart [19].
Nonetheless, the case of iNOS is different from eNOS and nNOS.
No kinase consensus phosphorylation sites have been found in this
region and still, this amino acid stretch is also limiting electron
transfer hence regulating the NO releasing activity of iNOS
[11,20]. Unlike its two constitutive counterparts, iNOS has a con-
sensus PDZ-domain-binding sequence at its carboxy-terminus.
Binding to proteins with PDZ domains such as EBP50 or CAP70 is
known to transport iNOS towards the apical side of polarized cells
where the vectorial NO release is known to occur [21,22]. In
macrophages EBP50 links iNOS to the actin cytoskeleton [23]. We
show herein that binding of PDZ domains to iNOS unleashes the
C-terminal autoinhibitory module. Three independent methods
show that PDZ binding to the C-terminus of iNOS increases its
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the formation of the air-stable semiquinone, augments the global
NO synthesis and induces a long-range conformational change
responsible for diminishing the Km for L-Arg. In summary, our data
indicate that iNOS binding to the PDZ domains of certain cellular
proteins not only affects its subcellular localization but also acti-
vates the enzyme in a similar fashion as phosphorylation does to
its constitutive counterparts.
2. Materials and methods
2.1. Materials
Buffers, chemicals, oligonucleotides and common laboratory
reagents were obtained from Sigma–Aldrich if not otherwise indi-
cated. Pfu polymerase, T4 DNA ligase, restriction endonucleases
and Molecular Mass markers were obtained from Fermentas.
Ni–NTA resin was from Qiagen. 20,50-ADP-Sepharose was from
Sigma–Aldrich. Sepharose 4B was from Pharmacia Fine
Chemicals. D(+)-Lactose monohydrate was from Scharlau. L-Arg
was from Calbiochem-Merck Bioscience.
2.2. Constructs
Using mouse macrophage iNOS as a template wild-type
full-length (residues 1–1144) or the C-terminal half of iNOS com-
prising the reductase domain (residues 495–1144), and their
respective C-terminal deletion mutants D5, D10 and D15, were
ampliﬁed, and NdeI and XbaI sites were introduced at the 50 and
30end, respectively. Expression was performed in the pCWori vec-
tor [24,25]. All constructs included the calmodulin binding
sequence and were veriﬁed by automated DNA sequencing.
Recombinant protein expression and puriﬁcation was performed
at 22 C in the Escherichia coli protease-deﬁcient strain BL21(DE3)
in coexpression with a calmodulin chloramphenicol-resistant
pACYC plasmid [26]. PDZ1 domain of EBP50 (residues 1–99) and
full-length CAP70 were expressed in pCWori or pKLSLt (kindly
provided by J. M. Mancheño [27]) respectively.
2.3. Reoxidation of reduced ﬂavins
The aerobic reoxidation of reduced ﬂavins was monitored at
459 nm for reductase domains (5 lM) in the presence of 50 mM
Tris, pH 7.0 plus 100 mM NaCl. 400-ll volume of sample was
pipetted and the absorbance was started to be registered at room
temperature. After 45 s NADPH was added at a ﬁnal concentration
of 20 lM and absorbance was registered for 6 min. When the effect
of the binding of the PDZ protein was assayed, iNOS (2.3 lM) was
preincubated with EBP50 (4.2 lM) for at least 1 h at room temper-
ature. NADPH was added at a ﬁnal concentration of 10 lM. When
spectral changes were recorded, NADPH concentration was
increased up to 75 lM to allow the recording of the reduced state
of ﬂavins (FADH2).
2.4. Cytochrome c reduction measurements, Griess assay, [14C]-L-Arg
to [14C-]-L-citrulline assay and determination of NO release using the
ﬂuorescent NO sensor DAF2-DA
The reductase activity of wild-type full-length iNOS and the
reductase domain as well as their respective C-terminal deletion
mutants was determined using cytochrome c as an electron accep-
tor after the increase in the absorbance at 550 nm at 37 C for
2 min as previously reported [22]. Every sample was analyzed in
triplicate. The enzymatic activity of iNOS was determined using
the Griess assay and also the conversion of [14C]-L-arginine to
[14C-]-L-citrulline conversion assay as previously reported [15,28].The Km for L-Arg for wild-type full-length iNOS after the binding
of CAP70 (12.6 lM) or EBP50 (25 lM) to the C-terminal end of
the enzyme was calculated using the Griess assay as previously
described [28,29]. The iNOS activity when transfected in COS-7
cells in the absence or presence of cotransfected EBP50 or CAP70
was determined as previously described [15,16] using the ﬂuores-
cent probe DAF2-DA (25 lM) known to react with NO.
3. Results
3.1. The C-terminal extension of iNOS restrains electron transfer
On top of nitric oxide synthases, three additional mammalian
proteins are known to bind FAD and FMN as well as the electron
donor NADPH. The ﬁrst gene of this family to be identiﬁed was
cytochrome P450 reductase although, more recently, both Novel
Reductase-1 [30] and Methionine Synthase Reductase [31] have
been identiﬁed as members of this group of enzymes. Sequence
comparison (Fig. 1) reveals that in three of these diﬂavin reduc-
tases the ﬁnal amino acid is coincident with the end of b-strand
23 and a conserved Trp residue at position-1 performs the aro-
matic stacking with the FAD moiety [32]. In contrast, all three
NOSs extend their sequences beyond this point and the aromatic
stacking with the FAD is performed by a conserved Phe residue.
In addition, a phosphorylatable Ser residue is present in both
nNOS and eNOS but is absent in the case of iNOS. We therefore per-
formed carboxy-terminal deletions in full-length iNOS and also in
its isolated reductase domain determining its cytochrome c reduc-
tion rates. Proteins were coexpressed with calmodulin in E. coli and
puriﬁed to homogeneity (Fig. 2A and B). Deletion of 5 amino acids
from the C-terminus of iNOS had a minimal effect on its ability to
transfer electrons to cytochrome c both in the case of full-length
iNOS (Fig. 2A) or its reductase domain (Fig. 2B). In contrast, dele-
tion of 10 amino acids increased approximately 1.6-fold the cyto-
chrome c reduction rate in the case of full-length iNOS (Fig. 2A).
C-terminal deletions of 10 and 15 amino acids were able to
increase electron transfer rates in the case of the isolated reductase
domain (Fig. 2B).
3.2. Binding of the PDZ domain of EBP50 and CAP70 to the C-terminus
of iNOS boosts electron transfer
Next, we decided to analyze the effect of EBP50 and CAP70, two
proteins with PDZ domains that bind to the C-terminus of iNOS, on
cytochrome c reduction. Recombinant expression of the ﬁrst PDZ
domain of EBP50 (Fig. 2C) and full-length CAP70 (Fig. 2D) was per-
formed in bacteria and the puriﬁed recombinant proteins were
incubated with the isolated reductase domain of iNOS. In concen-
trations ranging from 0 to 20 lM both proteins signiﬁcantly aug-
mented the reductase activity up to almost 2.8-fold in the case of
EBP50 and 1.8-fold in the case of CAP70 (Fig. 2C and D). No increase
was observed when the C-terminally truncated iNOS mutants were
incubated with either EBP50 or CAP70 (data not shown).
3.3. Both C-terminal deletions of iNOS or binding to PDZ domains
equally promote the formation of the air-stable semiquinone in the
reductase domain
It has been shown that when NOSs consume all the available
NADPH and catalysis stops, the enzymes return eventually to their
resting, fully oxidized state, but only after a transient period in a
partially reduced state. If the absorbance plateaus at the same
absorbance as it started, the ﬂavins have been fully reoxidized,
whereas if it regains only a portion of the absorbance change, a
semiquinone form is present. This state has been assigned to an
FAD–FMNH air-stable semiquinone that can persist for at least
Fig. 1. Sequence alignment of the carboxy-terminus of the six mammalian proteins known to bind FAD, FMN and NADPH using the Clustal software [41] (only the NADPH
binding domain is shown for clarity). a-Helices are shown as rectangles whereas b-strands are shown as horizontal arrows. The sequences shown correspond to Novel
Reductase-1 (NR1), Cytochrome P450 reductase (CYPOR), nNOS, eNOS, iNOS and Methionine Synthase Reductase (MetSRed). Please note that the three NOSs extend beyond
b-strand 23 with a carboxy-terminal stretch of variable length. The brown triangle marks the FAD aromatic stacking residues. Elements of secondary structure were inferred
from the nNOS crystal structure [32] (PDB accession 1TLL). The phosphorylatable residue within the C-terminal extension of nNOS and eNOS is marked with a vertical blue
arrow. An asterisk marks the position of iNOS Tyr1055, a residue known to be phosphorylated by src and conserved among the other reductases shown. The iNOS C-terminus,
known to bind to PDZ domains is underlined.
Fig. 2. The iNOS C-terminus is a key element that regulates its reductase activity. Carboxy-terminus deletion mutants of full-length iNOS (A) or its reductase domain
(residues 495–1144) (B) were created and tested for their cytochrome c reduction activity. Coomassie blue stained PAGE–SDS gels are shown to the left whereas the
quantiﬁcation of the reductase activity is shown to the right. The low molecular weight band appearing in the bottom of the panel B gel corresponds to calmodulin. *P < 0.05
versus absence of PDZ protein. Increment in the cytochrome c reduction activity of the iNOS reductase domain (residues 495–1144) when incubated with EBP50 (C) or CAP70
(D). The left panels show the Coomassie blue stained gels of the recombinant ﬁrst PDZ domain of EBP50 and full-length CAP70. The reductase activity was referred to 100% for
the wild-type protein (A and B) or to iNOS in the absence of added PDZ protein (C and D). Each point was analyzed in triplicate; mean ± S.D.
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Wild-type iNOS reductase (green trace in Fig. 3A) and the deletion
mutants described herein are all puriﬁed with the ﬂavins in the
fully oxidized state. To determine whether the C-terminal exten-
sion of iNOS affects this process, the rate of ﬂavin reoxidation
was analyzed for the full-length and truncated iNOS reductase con-
structs. When the reductase domain of iNOS is incubated with theelectron donor NADPH it rapidly forms an air-unstable semiqui-
none and upon reduction, the 457 nm peak decreases. The two typ-
ical absorption peaks at 520 and 596 nm start appearing (black
trace in Fig. 3A) [35]. This semiquinone showed the characteristic
spectrum of a neutral (blue) semiquinone species [34,35]. This
unstable form then becomes oxidized and forms an air-stable
semiquinone (red trace in Fig. 3A).
Fig. 3. (A) Absorption spectra of wild-type iNOS reductase domain as puriﬁed (FAD-
green line) and upon aerobic reduction with 20 lM NADPH. Formation of the air-
stable semiquinone was conﬁrmed after recording the absorption spectrum for
300 s (red line). The reaction contained 5 lM enzyme in 50 mM Tris, pH 7.0 plus
100 mM NaCl. (B) The formation of the air-stable semiquinone was also determined
for the iNOS reductases with carboxy-terminal deletions. The ﬂavin reoxidation of
wild-type iNOS reductase domain (green line), the D10 mutant (red line) and the
D15 mutant (purple line) was monitored at 459 nm after the complete reduction
attained through the addition of 20 lM NADPH. Protein concentration was 5 lM in
all cases and the reaction buffer contained 50 mM Tris, pH 7.0 plus 100 mM NaCl.
The absorbance value of the reduced sample was plotted as 0 for clarity. Formation
of the air-stable semiquinone was analyzed for a 5 min period. (C) The formation of
the air-stable semiquinone was also determined for the wild-type iNOS reductase in
the presence and absence of the ﬁrst PDZ domain of EBP50. The ﬂavin reoxidation of
wild-type iNOS reductase domain in the absence (light blue) or presence (dark blue)
of EBP50 was monitored at 459 nm after the complete reduction attained through
the addition of 20 lM NADPH. Protein concentration was 2.3 lM iNOS, 4.2 lM
EBP50 and in all cases the reaction buffer contained 50 mM Tris, pH 7.0 plus
100 mM NaCl. The absorbance value of the reduced sample was plotted as 0 for
clarity. Formation of the air-stable semiquinone was analyzed for a 5 min period.
The experiments shown are representative of six individual experiments performed
with two different protein preparations.
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quinone typically occurs within seconds with a t1/2 for this conver-
sion of approximately 90 s (green trace in Fig. 3B). In contrast,
formation of the air-stable one electron-reduced semiquinone isaccelerated both in the D10 reductase mutant (red line) and even
to a greater extent in the D15 mutant (purple line). Hence, the
removal of the C-terminal tail residues has a clear effect on the
function of the reductase domain and is indicative that the trun-
cated iNOS reductase constructs transfer electrons faster from
NADPH into the FAD moiety that the wild-type counterpart.
Interestingly, as shown in Fig. 3C, binding of EBP50 to iNOS reduc-
tase accelerates the formation of the one electron-reduced FAD–
FMNH semiquinone approximately by 40 s, an observation that is
in agreement with the augmented electron transfer rate observed
in the presence of EBP50 or CAP70 previously reported.
3.4. iNOS binding to CAP70 and EBP50 dose-dependently increases
nitric oxide synthesis
During iNOS catalysis, the FAD moiety receives a hydride from
NADPH and then, sequentially, passes electrons to the FMN cofac-
tor. Ultimately, the 2-electron reduced FMN hydroquinone trans-
fers electrons to the heme group located in the oxygenase
domain of the partner subunit of the iNOS dimer [36,37]. Since
binding of PDZ domains to the reductase domain of iNOS removed
the autoinhibitory C-terminal element and increased electron
transfer we next analyzed whether the activity of EBP50 and
CAP70 to full-length iNOS equally increased NO synthesis.
Incubation of full-length iNOS with increasing concentrations of
the ﬁrst PDZ domain of EBP50 or with full-length CAP70 resulted
in an augmented iNOS activity, reaching a 1.3-fold and
1.5-fold increase respectively (Fig. 4A). Likewise, both EBP50
and CAP70 signiﬁcantly augmented iNOS activity when cotrans-
fected in mammalian cells. This effect could be determined upon
measuring [14C]-L-arginine to [14C]-L-citrulline conversion
(Fig. 4B) or NO reaction with the ﬂuorescent probe DAF2-DA
(Fig. 4C). Hence, binding of PDZ domains and displacement of the
iNOS autoinhibitory module leads not only to augmented electron
transfer rates of the iNOS reductase domain (Fig. 2) and to an
enhanced rate of formation of the air-stable semiquinone
(Fig. 3C) but also to an increased catalytic activity.
3.5. Binding of PDZ domains to the C-terminus of iNOS decreases the
Km for L-Arg
Activation of interdomain electron transfer in all three NOSs is
thought to require a relative large (70 Å) movement of the FMN
subdomain [32,37]. The perfect adjustment between the reductase
and heme-oxygenase domains is thought to be achieved through
the correct positioning of the calmodulin moiety and two hinge
elements (referred to as H1 and H2) [37]. With that in mind, next,
we assessed whether binding of a PDZ domain to the C-terminus of
iNOS and the subsequent removal of the autoinhibitory element
could result in changes in the heme oxygenase domain.
Speciﬁcally, we performed iNOS activity assays in the absence or
presence of recombinant EBP50 and CAP70, which remove the
autoinhibitory element, and determined the Km for its substrate
L-Arg. The conformational change induced upon iNOS binding to
a PDZ domain also affects the Km for L-Arg, decreasing from
35.8 ± 2.7 lM in the absence of added proteins (in agreement with
previous reports [13,38]) to 26.3 ± 1.0 lM in the presence of EBP50
or to 27.4 ± 2.1 lM in the presence of CAP70.
4. Discussion
The presence of a long autoinhibitory extension at the
C-terminus of all known iNOS enzymes (21 amino acids for mouse
macrophage iNOS) is somehow puzzling since no phosphorylation
sites have been identiﬁed in this stretch. Previous studies have
Fig. 4. Binding of EBP50 and CAP70 to the C-terminus of iNOS results in increased production of nitric oxide. (A) Wild-type full-length iNOS (55 nM) was incubated with
increasing amounts of PDZ1 domain of EBP50 (left panel) or CAP70 (right panel) and levels of NO were determined using the Griess assay. The activity was referred to 100% in
the absence of added PDZ protein. Each point was analyzed in triplicate; mean ± S.D. (B) COS-7 cells were transfected with full-length wild-type iNOS alone () or together
with full-length CAP70 or EBP50. One day post-transfection the medium was replaced and 48 h after transfection cells were harvested, sonicated for 5 s and conversion of
[14C]-L-Arg to [14C]-L-Cit was analyzed [15]. The resulting [14C]-L-Cit measurement obtained for non-transfected cells was subtracted from each condition and the [14C]-L-Arg
to [14C]-L-Cit conversion (%) was referred to cells transfected with iNOS to which a 100% conversion was assigned. Data are mean ± S.E.M. for 3 independent experiments.
*P < 0.05 in relation to cells transfected only with iNOS. (C) COS-7 cells were transfected with empty pcDNA3 plasmid or with full-length wild-type iNOS together or not with a
construct for CAP70, EBP50 or empty plasmid. One day post-transfection the medium was replaced with fresh medium with additional L-Arg (5 mM)/H4B (15 lM) and 48 h
after transfection cells were washed with medium and incubated with the ﬂuorescent NO sensor DAF2-DA (25 lM). Released NO was allowed to react with DAF2-DA for 4 h.
Fluorescence was quantiﬁed through pixel to pixel intensity determination and the resulting ﬂuorescence corresponding to cells transfected with the empty vector (DAF) was
subtracted from each condition (plot). Data are mean ± S.D. for four determinations. *P < 0.05 in relation to cells transfected only with iNOS.
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activity that was 10-fold higher than its non-truncated form and,
using stopped-ﬂow spectrophotometry, it was shown that electron
transfer into and between the two ﬂavins and from the ﬂavin to the
heme domain was 2–5-fold faster [20]. However, this truncated
iNOS, which lacked 21 residues, catalyzed NO formation only
slightly faster than the intact form and was unable to form an
air-stable semiquinone upon reduction with NADPH [20].
Consequently, we then decided to clone and purify truncated
iNOS full-length proteins in which 5, 10 or 15 amino acids were
missing. We show herein that, indeed, the iNOS C-terminal module
restricts electron transfer since the truncated proteins reduced
cytochrome c more efﬁciently than their full-length counterpart.
Likewise, iNOS reductase domains in which 5 or 10 amino acids
from the C-terminus have been deleted anticipated the formation
of an air-stable semiquinone in the presence of NADPH.
We next analyzed the effect of two proteins that have either
two (EBP50) or four (CAP70) PDZ domains on iNOS activity, both
of which are known to bind to the C-terminus end of iNOS being
responsible for its apical targeting in polarized cells [21,22].
Consistent with the role of the autoinhibitory module in iNOS elec-
tron transfer and overall activity we incubated either the puriﬁed
reductase domain of iNOS or the full-length enzyme with these
PDZ domains and observed that not only the rate of electron
transfer (reductase activity) was augmented but also NO synthesis.
The anticipated formation of the air-stable semiquinone of the
reductase domain in the presence of the recombinant PDZ1 mod-
ule of EBP50 clearly indicates that the autoinhibitory element has
been removed and electron transfer is no longer impeded.
Hence, our results indicate that, in a cellular environment, the
apical targeting of iNOS might proceed with a concomitant boost
in NO synthesis. For instance, the interaction of iNOS with EBP50
would determine its apical distribution and the eventual associa-
tion with the cortical actin cytoskeleton where NO becomes
released [21]. This selective release of NO at discrete cellular local-
izations might be imperative not only in polarized cells that
respond to pro-inﬂammatory stimuli such as epithelial cells but
also in the case of macrophages.Finally, it is noteworthy that iNOS is active only as a homodimer
and it has been previously shown that binding to CAP70 promotes
iNOS dimerization [22]. However, most of the interactions that
mediate dimerization between iNOS monomers are considered to
lie in the N-terminal heme oxygenase domain [39,40]. That led
us to consider if binding of EBP50 or CAP70 to the C-terminus of
iNOS might result in dimer stabilization and long-range conforma-
tional changes within the heme-oxygenase domain as well. Our
results indeed show a moderate but reproducible decrease in the
iNOS Km for L-Arg when a PDZ domain binds to its ﬁnal four amino
acids, a behavior that might prove useful when substrate concen-
trations become limiting.
Collectively, our present data revealed that the C-terminus of
iNOS regulates enzymatic activity alternating between an autoin-
hibitory state and a displaced state in which electron transfer is
increased. Using recombinant proteins with PDZ domains known
to bind to the C-terminus of iNOS we show that activation pro-
ceeds through an increased reductase activity that is reﬂected in
augmented NO synthesis both in puriﬁed iNOS and within COS-7
cells. Future studies might identify factors that, through the dis-
ruption of this association of iNOS with proteins that display PDZ
domains could decrease deleterious NO levels in inﬂammatory
pathologies in which high iNOS activity might be detrimental.
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